STAANasdaqOphthalmic GoodsFiscal year ends January 2
STAAR SURGICAL CO
Financials through Q2 FY2026, quarter ended Jul 3, 2026Last filing: 10-Q on Aug 12, 2026
$21.88+0.61 (+2.87%)
Close on Oct 19, 2026
- Market cap
- $1.13B
- P/E (TTM)
- 312.6
- Dividend yield
- –
STAAR SURGICAL CO revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IOLs [Member] | – | – | – | – | – | $13.57M | $15.69M | $16.19M | $17.26M | $19.71M | – | – |
| Other surgical products [Member] | – | – | – | – | – | $8.48M | $5.17M | $6.68M | $5.03M | $3.62M | – | – |
| ICLs [Member] | – | $312.54M | $319.43M | $269.71M | $212.91M | $141.41M | $129.32M | $101.08M | $68.33M | $59.11M | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | – | – | – | – | – | – | $7.32M | $7.89M | $9.86M | – | – |
| South Korea | – | – | – | – | – | – | – | – | $5.54M | $7.46M | – | – |
| China | – | – | – | – | – | – | – | $46.07M | $24.47M | $16.62M | – | – |
| Japan | – | – | – | – | – | – | – | $23.15M | $18.13M | $17.33M | – | – |
| Other Countries [Member] | – | – | – | – | – | – | – | $47.42M | $40.12M | $38.62M | – | – |
From the segment and revenue-disaggregation notes of Staar Surgical's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.